J Stroke.  2023 Jan;25(1):169-172. 10.5853/jos.2022.02145.

Association of Substantia Nigra Degeneration with Poor Neurological Recovery in Basal Ganglia Infarctions

• Lee K
• Lee H
• Kim YD
• Nam HS
• Lee HS
• Yoo J
• Cho S
• Heo JH

• KMID: 2539070
• DOI: http://doi.org/10.5853/jos.2022.02145

Figure

• 

  Figure 1. Percent improvement in National Institutes of Health Stroke Scale (NIHSS) scores on day 14 after stroke. Patients with substantia nigra (SN) degeneration showed less neurological improvement. *P=0.04.

Reference

References

1. Rodriguez-Grande B, Blackabey V, Gittens B, Pinteaux E, Denes A. Loss of substance P and inflammation precede delayed neurodegeneration in the substantia nigra after cerebral ischemia. Brain Behav Immun. 2013; 29:51–61.

2. Nakajima M, Inatomi Y, Okigawa T, Yonehara T, Hirano T. Secondary signal change and an apparent diffusion coefficient decrease of the substantia nigra after striatal infarction. Stroke. 2013; 44:213–216.

3. Ogawa T, Okudera T, Inugami A, Noguchi K, Kado H, Yoshida Y, et al. Degeneration of the ipsilateral substantia nigra after striatal infarction: evaluation with MR imaging. Radiology. 1997; 204:847–851.

4. Winter B, Brunecker P, Fiebach JB, Jungehulsing GJ, Kronenberg G, Endres M. Striatal infarction elicits secondary extrafocal MRI changes in ipsilateral substantia nigra. PLoS One. 2015; 10:e0136483.

5. Park KW, Ju H, Kim ID, Cave JW, Guo Y, Wang W, et al. Delayed infiltration of peripheral monocyte contributes to phagocytosis and transneuronal degeneration in chronic stroke. Stroke. 2022; 53:2377–2388.

6. Heo JH, Song D, Nam HS, Kim EY, Kim YD, Lee KY, et al. Effect and safety of rosuvastatin in acute ischemic stroke. J Stroke. 2016; 18:87–95.

7. Yoo J, Baek JH, Park H, Song D, Kim K, Hwang IG, et al. Thrombus volume as a predictor of nonrecanalization after intravenous thrombolysis in acute stroke. Stroke. 2018; 49:2108–2115.

8. Forno LS. Reaction of the substantia nigra to massive basal ganglia infarction. Acta Neuropathol. 1983; 62:96–102.

9. Hosp JA, Greiner KL, Martinez Arellano L, Roth F, Löffler F, Reis J, et al. Progressive secondary exo-focal dopaminergic neurodegeneration occurs in not directly connected midbrain nuclei after pure motor-cortical stroke. Exp Neurol. 2020; 327:113211.

10. Zhang J, Zhang Y, Xing S, Liang Z, Zeng J. Secondary neurodegeneration in remote regions after focal cerebral infarction: a new target for stroke management? Stroke. 2012; 43:1700–1705.